HTFL
Get informed when a big investor buys or sells
+ FollowOvervalued by 70.7% based on the discounted cash flow analysis.
| Market cap | $4.29 Billion |
|---|---|
| Enterprise Value | $4.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.37 |
| Beta | 2.02 |
| Outstanding Shares | 86,398,778 |
| P/E Ratio | -35.03 |
|---|---|
| PEG | -49.2 |
| Price to Sales | 27.91 |
| Price to Book Ratio | 18.61 |
| Enterprise Value to Revenue | 20.19 |
| Enterprise Value to EBIT | -37.24 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 34.04% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.28%▼ 20.11% |
|---|---|
| Total Invested | $11.57M▼ 99.47% |
| Investors Holding | 17▼ 183.00% |
No data
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial inte...